naltrexone and HIV

naltrexone has been researched along with HIV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, ST; Bryant, KJ; Edelman, EJ; Fiellin, DA; Fiellin, LE; Hansen, N; Holt, SR; Justice, AC; Kyriakides, TC; Moore, BA; Virata, M1
Douglas, SD; Guo, CJ; Ho, WZ; Li, Y; Tian, S; Wang, X1

Trials

1 trial(s) available for naltrexone and HIV

ArticleYear
Efficacy of Extended-Release Naltrexone on HIV-Related and Drinking Outcomes Among HIV-Positive Patients: A Randomized-Controlled Trial.
    AIDS and behavior, 2019, Volume: 23, Issue:1

    Topics: Adult; Alcohol Drinking; Alcoholism; Anti-Retroviral Agents; CD4 Lymphocyte Count; Counseling; Delayed-Action Preparations; Double-Blind Method; Female; HIV; HIV Infections; Humans; Injections, Intramuscular; Male; Medication Adherence; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome

2019

Other Studies

1 other study(ies) available for naltrexone and HIV

ArticleYear
Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.
    Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2002, Volume: 50, Issue:6

    Topics: Chemokines, CC; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; HIV; Humans; Macrophages; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Phagocytosis; Receptors, CCR5; Species Specificity; Up-Regulation; Virus Replication

2002